Catalogs from Amsbio
Cryopreservation of Organoids
Freezing organoids doesn’t have to be time-consuming or complicated. CELLBANKER® from Amsbio offers a GMP-compliant, chemically defined cell freezing medium that ensures exceptional post-thaw performance — ideal for organoid storage, drug sensitivity assays, and maintaining genetic integrity. Unlike traditional FBS/DMSO-based methods that require slow cooling and shared freezing equipment, CELLBANKER® allows for direct transfer to the freezer, simplifying workflows and improving reproducibility. Researchers have found their organoids thrive after thawing, comparable to standard methods — but with far less hassle. Released November 2025.
Cellbanker® Cryopreservation
The CELLBANKER® series offers a comprehensive range of cryopreservation solutions designed for high cell viability, recovery, and ease of use. With ready-to-use formulations that eliminate the need for complex preparation, CELLBANKER® ensures reproducibility and long-term stability across diverse applications, including stem cell and organoid storage, as well as GMP-compliant bioprocessing. Options include serum-free, animal-free, and customized formats, making it the ideal choice for both research and clinical applications. Released September 2025.
Stemfit® - Weekend-free Stem Cell Culture
StemFit® by Amsbio is a comprehensive, animal-origin-free, chemically defined product range designed to support every stage of stem cell research. From the maintenance and expansion of human pluripotent stem cells (iPSCs and ESCs) to their differentiation into diverse lineages, StemFit® provides consistent, high-quality results. StemFit® hPSC Culture Media enables optimal feeder-free growth and expansion, while StemFit® for Differentiation offers a precisely formulated supplement to promote reliable and reproducible lineage-specific outcomes. Released September 2025.
Expanded Stem Cell Synergy by Amsbio
Stem cells are essential in pharmaceutical R&D and biotherapeutics manufacturing, with broad applications in regenerative medicine. Yet research is often costly and complex, requiring multiple products from different providers, which adds time, variability, and challenges when scaling up. The Amsbio Expanded Stem Cell Synergy Solutions portfolio provides an extensive range of fully defined GMP or GMP-equivalent products designed to work seamlessly together, covering the entire stem cell workflow from start to finish. Released September 2025.
iMatrix - Recombinant Human Laminin E8 Fragments
Enhance stem cell workflows with Amsbio’s iMatrix, recombinant laminin E8 fragments that provide defined, xeno-free substrates for specific cell types and lineage outcomes. Each isoform ensures consistent control over adhesion, proliferation, and differentiation by mimicking native extracellular matrix signals. Unlike traditional ECMs such as Matrigel™, iMatrix delivers reliable performance across applications, from pluripotent stem cell maintenance to endothelial, epithelial, and muscle cell growth. The series includes highly purified E8 fragments of laminin-511, -111, -221, -332, and -411. Released September 2025.